We think that thalassemia is not necessarily a cause of aggravation of the clinical course in COVID-19; however, certain key factors must be considered, such as the anemic condition, the likely pathogenic role of the virus on hemoglobin, and the hypercoagulable state to prevent any complications.
Keywords: COVID‐19; pneumonia; thalassemia.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.